Navigation Links
Engineered eggshells to help make hydrogen fuel
Date:9/26/2007

ive carbon dioxide absorber ever tested.

Energy experts believe that hydrogen may become an important power source in the future, most notably in the form of fuel cells. But first, researchers must develop affordable ways to produce large quantities of hydrogen -- and that means finding ways to deal with the byproducts of chemical reactions that produce the gas.

According to the United States Department of Agriculture, the country produced nearly 91 billion eggs in 2006. That equates to about 455,000 tons of shell per year that could potentially be used in hydrogen production.

Still, Fan said, even if all that shell were utilized, it would only provide a portion of what the United States would need to seriously pursue a hydrogen economy.

"Eggshell alone may not be adequate to produce hydrogen for the whole country, but at least we can use eggshell in a better way compared to dumping it as organic waste in landfills, where companies have to pay up to $40 dollars per ton disposal cost," he said.

Before they could grind up the egg shell, the engineers needed to remove the collagen-containing membrane that clings to the inside; they developed an organic acid that does the job. About 10 percent of the membrane consists of collagen, which sells for about $ 1000/gram. This collagen, once extracted, can be used in food or pharmaceuticals, or for medical treatments. Doctors use collagen to help burn victims regenerate skin; it's also used in cosmetic surgery.

"We like that our technology can help the egg industry to dispose of its waste, and at the same time convert the waste to a useful product," Fan said.

"And in the long term, we're demonstrating that carbon-based fuel sources, like coal or biomass, can be efficiently converted to hydrogen and liquid fuel. The goal is an energy conversion system that uses a dependable fossil energy source, but at the same time has very little environmental impact."

F
'/>"/>

Contact: L.S. Fan
Fan.1@osu.edu
614-688-3262
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Insects develop resistance to engineered crops
2. Engineered molecule amplifies bodys immune response
3. Engineered skin offers clues to melanoma development
4. Genetically engineered animals help in scientific research that may benefit children
5. Engineered Stem Cells Show Promise For Sneaking Drugs Into The Brain
6. Engineered mouse mimics cognitive aspects of schizophrenia
7. Genetically engineered mosquitoes show resistance to dengue fever virus
8. Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure
9. Bioengineered tissue implants regenerate damaged knee cartilage
10. New engineered drug may offer prolonged arthritis relief
11. Engineered yeast speeds ethanol production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2
... promising new class of drug designed to target the ... system, some of the HCV strains being treated exhibited ... team of Florida State University biologists, chemists and biomedical ... identify the drug-resistant HCV strains and the molecular-level mechanisms ...
... powerful new ability to engineer the flavor and aroma of ... publishing the most comprehensive deciphering of the beer,s "proteome" ever ... that make beer "beer") appears in ACS, monthly Journal ... say they were inspired to do the research by a ...
... has "significant" potential for preventing cardiomyopathy, a form of heart ... with diabetes, scientists have concluded in a new study. Their ... high risk for diabetic cardiomyopathy, appears in ACS, bi-weekly ... and colleagues note that people with diabetes have at least ...
Cached Biology News:Hepatitis C virus faces new weapon from Florida State scientists 2Hepatitis C virus faces new weapon from Florida State scientists 3
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... LOS ANGELES , May 21, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... 2 clinical trial with aldoxorubicin for the treatment ... of brain cancer.  The open-label, multisite trial is ... of aldoxorubicin in patients whose tumors have progressed ...
(Date:5/21/2015)... 20, 2015 Research and Markets ... the "2015 Global Survey on Flow Cytometry ... The primary goal of this research is ... and reagents. Key information the survey seeks to ... flow cytometers, predominantly used applications for flow cytometers, ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
... Feb. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences ... that on February 2, 2009 it received a letter ... the Company that the Panel has determined to grant ... Capital Market. The Panel granted the Company through ...
... CRY ), a biomaterials, medical device and tissue ... end financial results will be released on Thursday, February 19, ... live webcast at 10:00 a.m. Eastern Time, February 19, 2009, ... session hosted by Steven G. Anderson, president and CEO of ...
... first kidney-targeted antisense drug for type 2 diabetes enters ... (Nasdaq: ISIS ) announced today it has ... drug that inhibits the production of sodium dependent glucose ... transporter responsible for glucose re-absorption in the kidney. ...
Cached Biology Technology:Nasdaq Panel Grants Advanced Life Sciences Request for Continued Listing on Nasdaq Stock Market 2CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results 2Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 2Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 3Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug 4
...
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Streptavidin-Horseradish Peroxidase Conjugate, ... to reporter enzyme molecules ... and in situ hybridization ... Blotting & Labeling & ...
Biology Products: